about
Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironmentMyeloid-derived suppressor cells as therapeutic target in hematological malignanciesCommon interactions between S100A4 and S100A9 defined by a novel chemical probeGeneration of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing miceCD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden.Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancerHuman S100A9 protein is stabilized by inflammatory stimuli via the formation of proteolytically-resistant homodimers.S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-κB(1.).Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine modelsS100 proteins in cancer.DAMPs, ageing, and cancer: The 'DAMP Hypothesis'.Trial Watch: Therapeutic vaccines in metastatic renal cell carcinomaComparative Proteomic Analysis of Two Uveitis Models in Lewis RatsInhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers.Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways.The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growthInflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseasesTasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment.Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production.Novel therapies for the treatment of advanced prostate cancer.S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabineFunctions of S100 proteins.Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCCTasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancerS100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.S100 protein family in human cancer.Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissueTasquinimod: a novel angiogenesis inhibitor-development in prostate cancer.A review of tasquinimod in the treatment of advanced prostate cancer.Tying the knot between cytokine and toll-like receptor signaling in gastrointestinal tract cancers.Recent advances revolutionize treatment of metastatic prostate cancer.Mechanisms of action of tasquinimod on the tumour microenvironment.Targeting danger-associated molecular patterns after myocardial infarction.The role of S100 proteins and their receptor RAGE in pancreatic cancer.Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 suppresses tumor growth in breast cancer-bearing mice by negatively regulating myeloid-derived suppressor cell functions.Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment.Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
P2860
Q24618224-81A75CA2-6D45-42EF-98A3-B3378908C2BAQ27010234-929EF597-78A1-49D7-9CB6-8219F0E65E35Q28487759-BDA243C8-4632-4D60-8AEB-34378B6F3102Q33721765-99ECF423-3F4F-4FAE-A178-A5E570D1F983Q34509563-7704883B-21E4-4CA0-A674-FA7615C70B06Q34608976-A145D718-D9B2-45E0-B899-B7056058FF77Q34692406-33C8B357-A8BD-44C9-9FCB-E975D6CC1123Q34700918-465DAA1A-5312-40C0-84B3-0034290852E1Q34973392-D38D14B0-ABAE-4012-A80D-EFE3E22F41A1Q35071167-8CB8E893-0C4E-4C45-8A9C-CA5DD80382B0Q35206368-A1BA6181-7B2E-462E-BA0E-FA2C02FB90B4Q35558632-882630D7-FB0E-45B5-A9F6-E2A9BC7AF8BEQ35799377-C1D8BD83-639A-40F7-AEF0-3385254AF985Q35889289-6E144B9C-2B11-4670-B4AE-250BEFFBF5ADQ35952745-2FAED0F0-5BA0-46F0-A5C2-E267DEAEA704Q35971858-D5AD7727-00CA-48D2-B954-6B2A9907E373Q36072831-78968491-4CF2-4A8D-8B6F-61015690821CQ36299678-517E4098-4EB0-4477-B4EA-B6A271541178Q36370409-585B5FC6-FC09-4507-B1DF-A12E4DDB6DDBQ36414066-3BB03D66-EFF2-4DE8-9C94-76ADCB47328AQ36665708-D944DD0F-0D66-4FAB-9596-9EC2E77321C2Q36735918-A775DD8B-C005-4671-BFF3-403A5268B1F6Q37001259-E9265559-39E4-4683-B17D-F44AF207B12BQ37046518-077C7116-2C45-40AD-8737-0AA4D2E2A9B2Q37113485-8F765F0E-BFDE-4362-8DC5-F1A3D066ADF0Q37436729-130EE2D2-F60E-4FDB-B6C7-F5851BAE465CQ37650123-C2A700C9-2CBA-4646-8403-63374E71D746Q37696662-BA636486-DA4C-436E-A747-15F785F80B7AQ38075446-A5293102-7F12-41D6-BFE9-BD26B5EE9706Q38105544-70F4E787-1DA9-43FD-8C4A-24DB6F60F4F7Q38109656-CF76A45B-3BC1-4A1E-BF9B-ED1A24855061Q38125501-0C6F718B-026F-4AF8-8D35-87BFA595A4BAQ38155757-240D3EC5-E059-46AB-BDB7-C7DCB7707615Q38595544-EA55A3E5-609F-40FF-88CE-9BB5F1963B97Q38598852-FAB498F9-9B4E-4503-BDA1-E282101BDC35Q38612982-5ED818B5-36F0-4FA6-BD3D-DDA9E73F17FFQ38812152-1A08D7CC-5DCE-4B5D-8227-F748CE30BB3EQ38816155-D80BB178-AFC5-41CC-9A94-73D7E63F89B1Q38959297-C6E0A6FC-9FE6-4784-957B-8CE3DD3E1371Q39079681-87D4FC23-DCBE-4D7A-BA46-E07B04F103BB
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
S100A9 interaction with TLR4 promotes tumor growth
@ast
S100A9 interaction with TLR4 promotes tumor growth
@en
S100A9 interaction with TLR4 promotes tumor growth
@en-gb
S100A9 interaction with TLR4 promotes tumor growth
@nl
type
label
S100A9 interaction with TLR4 promotes tumor growth
@ast
S100A9 interaction with TLR4 promotes tumor growth
@en
S100A9 interaction with TLR4 promotes tumor growth
@en-gb
S100A9 interaction with TLR4 promotes tumor growth
@nl
altLabel
S100A9 Interaction with TLR4 Promotes Tumor Growth
@en
prefLabel
S100A9 interaction with TLR4 promotes tumor growth
@ast
S100A9 interaction with TLR4 promotes tumor growth
@en
S100A9 interaction with TLR4 promotes tumor growth
@en-gb
S100A9 interaction with TLR4 promotes tumor growth
@nl
P2093
P2860
P3181
P1433
P1476
S100A9 interaction with TLR4 promotes tumor growth
@en
P2093
Anders Bergh
Anders Olsson
David Liberg
Eva Källberg
Fredrik Ivars
Johannes Roth
Pernilla Wikström
Tomas Leanderson
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0034207
P407
P577
2012-01-01T00:00:00Z